This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mundhenke, C. Articles by Friedl, A. Search for Related Content PubMed PubMed Citation Articles by Mundhenke, C. Articles by Friedl, A.

(American Journal of Pathology. 2002;160:185-194.)
© 2002 American Society for Investigative Pathology

Regular Articles

Heparan Sulfate Proteoglycans as Regulators of Fibroblast Growth Factor-2 Receptor Binding in Breast Carcinomas

From the Department of Pathology and Laboratory Medicine,University of Wisconsin–Madison, Madison, Wisconsin

Binding of fibroblast growth factors (FGFs) to their tyrosine kinase-signaling receptors (FGFRs) requires heparan sulfate (HS). HS proteoglycans (HSPGs) determine mitogenic responses of breast carcinoma cells to FGF-2 in vitro. For this study, we examined the role of HSPGs as modulators of FGF-2 binding to FGFR-1 in situ and in vitro. During stepwise reconstitution of the FGF-2/HSPG/FGFR-1 complex in situ, we identified an elevated ability of breast carcinoma cell HSPGs to promote receptor complex formation compared to normal breast epithelium. HSPGs isolated from the MCF-7 breast-carcinoma cell line were then fractionated according to their ability to assemble the FGF-2 receptor complex. All MCF-7 HSPGs are decorated with HS chains similarly capable of promoting FGF-2 receptor complex formation. In this in vitro model, syndecan-1 and syndecan-4 are the cell surface HSPGs contributing most to the complex formation. Relative expression levels of these syndecans in human breast carcinoma tissues correlate well with receptor complex formation in situ, indicating that in breast carcinomas, core protein levels determine FGF-2 receptor complex formation. However, variances in syndecan expression levels do not explain the difference in FGF-2 receptor complex formation between normal and malignant epithelial cells, suggesting that alterations in HS structure occur during malignant transformation.

This article has been cited by other articles:

				G. Su, S. A. Blaine, D. Qiao, and A. Friedl Shedding of Syndecan-1 by Stromal Fibroblasts Stimulates Human Breast Cancer Cell Proliferation via FGF2 Activation J. Biol. Chem., May 18, 2007; 282(20): 14906 - 14915. [Abstract] [Full Text] [PDF]

				X. Xu, G. Rao, R. M. Quiros, A. W. Kim, H.-Q. Miao, G. J. Brunn, J. L. Platt, P. Gattuso, and R. A. Prinz In Vivo and in Vitro Degradation of Heparan Sulfate (HS) Proteoglycans by HPR1 in Pancreatic Adenocarcinomas: LOSS OF CELL SURFACE HS SUPPRESSES FIBROBLAST GROWTH FACTOR 2-MEDIATED CELL SIGNALING AND PROLIFERATION J. Biol. Chem., January 26, 2007; 282(4): 2363 - 2373. [Abstract] [Full Text] [PDF]

				S. E. Ali-Khan and B. F. Hales Novel Retinoid Targets in the Mouse Limb during Organogenesis Toxicol. Sci., November 1, 2006; 94(1): 139 - 152. [Abstract] [Full Text] [PDF]

				G. Su, K. Meyer, C. D. Nandini, D. Qiao, S. Salamat, and A. Friedl Glypican-1 Is Frequently Overexpressed in Human Gliomas and Enhances FGF-2 Signaling in Glioma Cells Am. J. Pathol., June 1, 2006; 168(6): 2014 - 2026. [Abstract] [Full Text] [PDF]

				T. Kelly, L. J. Suva, Y. Huang, V. MacLeod, H.-Q. Miao, R. C. Walker, and R. D. Sanderson Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases Cancer Res., July 1, 2005; 65(13): 5778 - 5784. [Abstract] [Full Text] [PDF]

				R. Haimov-Kochman, D. Prus, E. Zcharia, D. S. Goldman-Wohl, S. Natanson-Yaron, C. Greenfield, E. Y. Anteby, R. Reich, J. Orly, A. Tsafriri, et al. Spatiotemporal Expression of Heparanase During Human and Rodent Ovarian Folliculogenesis Biol Reprod, July 1, 2005; 73(1): 20 - 28. [Abstract] [Full Text] [PDF]

				M. K. Whitworth, A. C. Backen, A. R. Clamp, G. Wilson, R. McVey, A. Friedl, A. C. Rapraeger, G. David, A. McGown, R. J. Slade, et al. Regulation of Fibroblast Growth Factor-2 Activity by Human Ovarian Cancer Tumor Endothelium Clin. Cancer Res., June 15, 2005; 11(12): 4282 - 4288. [Abstract] [Full Text] [PDF]

				T. Maeda, C. M. Alexander, and A. Friedl Induction of Syndecan-1 Expression in Stromal Fibroblasts Promotes Proliferation of Human Breast Cancer Cells Cancer Res., January 15, 2004; 64(2): 612 - 621. [Abstract] [Full Text] [PDF]

				D. Qiao, K. Meyer, C. Mundhenke, S. A. Drew, and A. Friedl Heparan Sulfate Proteoglycans as Regulators of Fibroblast Growth Factor-2 Signaling in Brain Endothelial Cells. SPECIFIC ROLE FOR GLYPICAN-1 IN GLIOMA ANGIOGENESIS J. Biol. Chem., April 25, 2003; 278(18): 16045 - 16053. [Abstract] [Full Text] [PDF]

				M. Ikeguchi, K. Fukuda, K.-i. Yamaguchi, A. Kondo, S.-i. Tsujitani, and N. Kaibara Quantitative Analysis of Heparanase Gene Expression in Esophageal Squamous Cell Carcinoma Ann. Surg. Oncol., April 1, 2003; 10(3): 297 - 304. [Abstract] [Full Text] [PDF]

				G. Thomas, A. Clayton, J. Thomas, M. Davies, and R. Steadman Structural and Functional Changes in Heparan Sulfate Proteoglycan Expression Associated with the Myofibroblastic Phenotype Am. J. Pathol., March 1, 2003; 162(3): 977 - 989. [Abstract] [Full Text] [PDF]